Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arylboron Tetraphenylethylene-Analog AIEgens Enabling Reversible Closed-Shell/Open-Shell Switching.

Journal of the American Chemical Society·2026
Same author

Breaking the blue limit of non-conjugated hydrocarbons via multiple through-space interactions.

National science review·2026
Same author

Integrated theranostic nanoplatform empowers precision cancer care via radionuclide-labeled NIR-II aggregation-induced emission luminogens.

Nature communications·2026
Same author

Injectable NIR-II Photothermal Hydrogels for Image-Guided Adipose Remodeling and Antiobesity Therapy.

ACS nano·2026
Same author

Microfluidic Assembly of NIR-II AIE Nanoparticles for Enhanced Photothermal Ablation of Breast Tumors.

Advanced healthcare materials·2026
Same author

Aggregation-Induced Emission: Past, Present, and Future.

Accounts of chemical research·2026

Related Experiment Video

Updated: Jul 28, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K

AIEgens for synergistic anticancer therapy.

Xinyan Lyu1, Junjie Yu1, Liping Zhang1

  • 1The Second Affiliated Hospital, School of Medicine, School of Science and Engineering, Shenzhen Institute of Aggregate Science and Technology, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China. zhaozheng@cuhk.edu.cn.

Journal of Materials Chemistry. B
|June 5, 2023
PubMed
Summary

Aggregate-induced emission luminogens (AIEgens) offer a novel approach to cancer phototherapy. These agents overcome limitations of traditional therapies by enhancing fluorescence and therapeutic effects in aggregate form, paving the way for advanced synergistic cancer treatments.

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Related Experiment Videos

Last Updated: Jul 28, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Conventional cancer therapies (surgery, chemotherapy, radiation) have limitations.
  • Synergistic therapies improve precision and efficacy by combining modalities.
  • Traditional organic phototherapeutic agents suffer from aggregation-induced quenching.

Purpose of the Study:

  • To review recent advancements in aggregate-induced emission luminogen (AIEgen)-based synergistic cancer therapy.
  • To highlight the advantages of AIEgens in phototherapy.
  • To explore the potential of AIE-based combination therapies for improved cancer treatment.

Main Methods:

  • Review of recent scientific literature on AIEgens in cancer therapy.
  • Analysis of AIEgen properties, including fluorescence and therapeutic effects in aggregate states.
  • Discussion of synergistic effects when combining AIE-based phototherapy with conventional treatments.

Main Results:

  • AIEgens exhibit bright fluorescence and potent therapeutic effects in aggregate form, overcoming limitations of traditional agents.
  • Combining AIE-based phototherapy with conventional therapies demonstrates significant synergistic effects.
  • AIEgens offer a promising platform for developing precise and effective cancer therapies.

Conclusions:

  • AIEgens represent a breakthrough in phototherapy, offering enhanced efficacy and overcoming aggregation-caused quenching.
  • AIE-based synergistic therapy holds significant potential for advancing accurate and effective cancer treatment strategies.
  • Further research into AIEgens will likely lead to novel therapeutic approaches for various cancers.